University of California San Francisco

Kim Rhoads
Kim Rhoads, MD, MPH

Associate Professor, Epidemiology & Biostatistics

Cancer Prevention Institute of California

Address

3333 California Street, #553
San Francisco, CA 94118
United States

Email: [email protected]

Grants and Funding

  • Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (RCC RD-MCD) | NIH | 2021-09-24 - 2026-06-30 | Role: Co-Principal Investigator
  • The quality of care in minority serving hospitals explains cancer disparities | NIH | 2012-04-01 - 2014-03-31 | Role: Principal Investigator

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 54
  1. Remedying Black cancer disparities with clinical research prioritization.
    Ashing K, Barrett N, Rhoads KF, Odedina F, Thompson H, Ragin C, Nolan TS, Sheppard VB| | PubMed
  2. The state of cancer-focused community outreach and engagement (COE): reflections of Black COE directors.
    Thompson HS, Ashing KT, Barrett NJ, Baskin ML, Carter-Bawa L, Nolan TS, Odedina FT, Rhoads KF, Sheppard VB, Zeigler-Johnson C| | PubMed
  3. Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES).
    Andemeskel G, Palmer NR, Pasick R, Van Blarigan EL, Kenfield SA, Graff RE, Shaw M, Yu W, Sanchez M, Hernandez R, Washington SL, Shariff-Marco S, Rhoads KF, Chan JM| | PubMed
  4. Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.
    Hun Kwak J, Mackin LA, Block A, Paul SM, Cooper BA, Abbott M, Chang SM, Hammer MJ, Kober KM, Levine JD, Pozzar R, Rhoads KF, Snowberg KE, Tsai KK, Van Blarigan EL, Van Loon K, Miaskowski C| | PubMed
  5. Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course.
    Sudat SEK, Wesson P, Rhoads KF, Brown S, Aboelata N, Pressman AR, Mani A, Azar KMJ| | PubMed
  6. Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.
    Greenberg AL, Brand NR, Zambeli-Ljepovic A, Barnes KE, Chiou SH, Rhoads KF, Adam MA, Sarin A| | PubMed
  7. Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial.
    Borno HT, Zhang L, Zhang S, Lin TK, Skafel A, Nieves E, Dornsife D, Johnson R, Rhoads K, Small E, Spicer D| | PubMed
  8. Accelerating cancer clinical trial recruitment through a financial reimbursement program integrated with patient navigation: an interrupted time series analysis.
    Borno HT, Lin TK, Zhang S, Skafel A, Lalanne A, Dornsife D, Johnson R, Spicer D, Small EJ, Rhoads KF| | PubMed
  9. Loneliness and symptom burden in oncology patients during the COVID-19 pandemic.
    Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno HT, Chang SM, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Kober KM, Laffan A, Levine JD, Pozzar R, Rhoads K, Tsai KK, Van Blarigan EL, Van Loon K| | PubMed
  10. Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.
    Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K| | PubMed
54
View all 54 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 54
  1. Remedying Black cancer disparities with clinical research prioritization.
    Ashing K, Barrett N, Rhoads KF, Odedina F, Thompson H, Ragin C, Nolan TS, Sheppard VB| | PubMed
  2. The state of cancer-focused community outreach and engagement (COE): reflections of Black COE directors.
    Thompson HS, Ashing KT, Barrett NJ, Baskin ML, Carter-Bawa L, Nolan TS, Odedina FT, Rhoads KF, Sheppard VB, Zeigler-Johnson C| | PubMed
  3. Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES).
    Andemeskel G, Palmer NR, Pasick R, Van Blarigan EL, Kenfield SA, Graff RE, Shaw M, Yu W, Sanchez M, Hernandez R, Washington SL, Shariff-Marco S, Rhoads KF, Chan JM| | PubMed
  4. Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.
    Hun Kwak J, Mackin LA, Block A, Paul SM, Cooper BA, Abbott M, Chang SM, Hammer MJ, Kober KM, Levine JD, Pozzar R, Rhoads KF, Snowberg KE, Tsai KK, Van Blarigan EL, Van Loon K, Miaskowski C| | PubMed
  5. Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course.
    Sudat SEK, Wesson P, Rhoads KF, Brown S, Aboelata N, Pressman AR, Mani A, Azar KMJ| | PubMed
  6. Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.
    Greenberg AL, Brand NR, Zambeli-Ljepovic A, Barnes KE, Chiou SH, Rhoads KF, Adam MA, Sarin A| | PubMed
  7. Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial.
    Borno HT, Zhang L, Zhang S, Lin TK, Skafel A, Nieves E, Dornsife D, Johnson R, Rhoads K, Small E, Spicer D| | PubMed
  8. Accelerating cancer clinical trial recruitment through a financial reimbursement program integrated with patient navigation: an interrupted time series analysis.
    Borno HT, Lin TK, Zhang S, Skafel A, Lalanne A, Dornsife D, Johnson R, Spicer D, Small EJ, Rhoads KF| | PubMed
  9. Loneliness and symptom burden in oncology patients during the COVID-19 pandemic.
    Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno HT, Chang SM, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Kober KM, Laffan A, Levine JD, Pozzar R, Rhoads K, Tsai KK, Van Blarigan EL, Van Loon K| | PubMed
  10. Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.
    Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K| | PubMed
  11. Quality Improvement at the Health System Level: Measurement, Risk Stratification, Disparity Populations, and Governance.
    Rocque GB, Lennes IT, Rhoads KF, Yu PP| | PubMed
  12. Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data: Negative Margin Rates and Neck Dissection Yield.
    Schoppy DW, Rhoads KF, Ma Y, Chen MM, Nussenbaum B, Orosco RK, Rosenthal EL, Divi V| | PubMed
  13. Inappropriate oophorectomy at time of benign premenopausal hysterectomy.
    Mahal AS, Rhoads KF, Elliott CS, Sokol ER| | PubMed
  14. Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer.
    Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, Shah JL, Hara W| | PubMed
  15. Predictors of readmission to non-index hospitals after colorectal surgery.
    Cloyd JM, Huang L, Ma Y, Rhoads KF| | PubMed
  16. Risks of adverse events in colorectal patients: population-based study.
    Hernandez-Boussard TM, McDonald KM, Morrison DE, Rhoads KF| | PubMed
  17. Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics.
    Divi V, Ma Y, Rhoads KF| | PubMed
  18. Knowing it When You See it: The Need for Continuing Innovation in Research on Healthcare Discrimination.
    Rhoads K, Dohan D| | PubMed
  19. Association Between Weekend Discharge and Hospital Readmission Rates Following Major Surgery.
    Cloyd JM, Chen J, Ma Y, Rhoads KF| | PubMed
  20. Reply to M.H. Kanter et al.
    Rhoads KF, Patel MI, Ma Y, Schmidt LA| | PubMed
  21. The role of the hospital and health care system characteristics in readmissions after major surgery in California.
    Chen JC, Shaw JD, Ma Y, Rhoads KF| | PubMed
  22. Is weekend discharge associated with hospital readmission?
    Cloyd JM, Chen JC, Ma Y, Rhoads KF| | PubMed
  23. Factors that influence minority use of high-volume hospitals for colorectal cancer care.
    Huang LC, Tran TB, Ma Y, Ngo JV, Rhoads KF| | PubMed
  24. Patient safety in plastic surgery: identifying areas for quality improvement efforts.
    Hernandez-Boussard T, McDonald KM, Rhoads KF, Curtin CM| | PubMed
  25. Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?
    Patel MI, Ma Y, Mitchell BS, Rhoads KF| | PubMed
  26. Compliance with gastric cancer guidelines is associated with improved outcomes.
    Worhunsky DJ, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF, Visser BC| | PubMed
  27. Collateral damage: taxane-induced colonic perforation.
    Erdrich J, Kastenberg ZJ, DiMaio MA, Longacre TA, Rhoads KF| | PubMed
  28. How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia?
    Patel MI, Ma Y, Mitchell B, Rhoads KF| | PubMed
  29. How do integrated health care systems address racial and ethnic disparities in colon cancer?
    Rhoads KF, Patel MI, Ma Y, Schmidt LA| | PubMed
  30. Integrated health systems and evidence-based care: standardizing treatment to eliminate cancer disparities.
    Patel MI, Rhoads KF| | PubMed
  31. Capsule commentary on Anderson et al., quality of care and racial disparities in medicare among potential ACOs.
    Rhoads KF| | PubMed
  32. Understanding the reliability of American College of Surgeons National Surgical Quality Improvement Program as a quality comparator.
    Rhoads KF, Wren SM| | PubMed
  33. Adequacy of lymph node examination in colorectal surgery: contribution of the hospital versus the surgeon.
    Rhoads KF, Ackerson LK, Ngo JV, Gray-Hazard FK, Subramanian SV, Dudley RA| | PubMed
  34. What factors influence minority use of National Cancer Institute-designated cancer centers?
    Huang LC, Ma Y, Ngo JV, Rhoads KF| | PubMed
  35. Surgical site infection: is it time to change our expectations?
    Rhoads KF| | PubMed
  36. Do hospitals that serve a high percentage of Medicaid patients perform well on evidence-based guidelines for colon cancer care?
    Rhoads KF, Ngo JV, Ma Y, Huang L, Welton ML, Dudley RA| | PubMed
  37. Predictors of postoperative urinary retention after colorectal surgery.
    Kin C, Rhoads KF, Jalali M, Shelton AA, Welton ML| | PubMed
  38. Improving the accuracy of prolapse and incontinence procedure epidemiology by utilizing both inpatient and outpatient data.
    Elliott CS, Rhoads KF, Comiter CV, Chen B, Sokol ER| | PubMed
  39. The influence of intern home call on objectively measured perioperative outcomes.
    Kastenberg ZJ, Rhoads KF, Melcher ML, Wren SM| | PubMed
  40. Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Patel MI, Rhoads KF, Ma Y, Ford JM, Visser BC, Kunz PL, Fisher GA, Chang DT, Koong A, Norton JA, Poultsides GA| | PubMed
  41. Understanding disparities in leukemia: a national study.
    Patel MI, Ma Y, Mitchell BS, Rhoads KF| | PubMed
  42. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
    Visser BC, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF| | PubMed
  43. Racial and ethnic differences in lymph node examination after colon cancer resection do not completely explain disparities in mortality.
    Rhoads KF, Cullen J, Ngo JV, Wren SM| | PubMed
  44. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type.
    Zak Y, Rhoads KF, Visser BC| | PubMed
  45. Variation in the quality of surgical care for uterovaginal prolapse.
    Rhoads KF, Sokol ER| | PubMed
  46. Understanding racial disparities in cancer treatment and outcomes.
    Morris AM, Rhoads KF, Stain SC, Birkmeyer JD| | PubMed
  47. Performance measurement, public reporting, and pay-for-performance.
    Rhoads KF, Konety BM, Dudley RA| | PubMed
  48. Quality of colon cancer outcomes in hospitals with a high percentage of Medicaid patients.
    Rhoads KF, Ackerson LK, Jha AK, Dudley RA| | PubMed
  49. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease.
    Kulstad JJ, Green PS, Cook DG, Watson GS, Reger MA, Baker LD, Plymate SR, Asthana S, Rhoads K, Mehta PD, Craft S| | PubMed
  50. A role for Hox A5 in regulating angiogenesis and vascular patterning.
    Rhoads K, Arderiu G, Charboneau A, Hansen SL, Hoffman W, Boudreau N| | PubMed
  51. Cholelithiasis and perforated gallbladder in an infant.
    Rhoads K, Snyder J, Lee H| | PubMed
  52. Breast Cancer Beliefs and Behaviors at the San Francisco General Hospital.
    Rhoads KF, Luce JA, Knudson MM| | PubMed
  53. Five-year follow-up for adverse outcomes in males with at least minimally positive angiograms: importance of "denial" in assessing psychosocial risk factors.
    Ketterer MW, Huffman J, Lumley MA, Wassef S, Gray L, Kenyon L, Kraft P, Brymer J, Rhoads K, Lovallo WR, Goldberg AD| | PubMed
  54. Is aspirin, as used for antithrombosis, an emotion-modulating agent?
    Ketterer MW, Brymer J, Rhoads K, Kraft P, Lovallo WR| | PubMed